Skip to main content
Top

09-05-2018 | Vasculitis | Case report | Article

The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis

Journal: Clinical Rheumatology

Authors: Marc-Etienne Parent, Maxime Richer, Patrick Liang

Publisher: Springer London

Abstract

To present an unrecognized vascular complication of bacillus Calmette-Guérin (BCG) therapy administered for superficial bladder carcinoma. We also review the potential mimickers for primary angiitis of the central nervous system (PACNS) as well as complications of intravesical BCG therapy. An 89-year-old Caucasian man with a history of relapsing high-grade bladder carcinoma treated with intravesical BCG presented with recurring episodes of right upper limb paresthesia with clumsiness and dysarthria. Magnetic resonance imaging of the head revealed multiple predominantly left-sided frontotemporal micronodular peri-vascular lesions. Left frontal lobe biopsy showed non-necrotizing granulomatous vasculitis. Ziehl staining was negative. Initially, he was treated for PACNS but his symptoms relapsed during every attempt to taper the corticosteroids. Six months later, he developed bilateral mycobacterial endophthalmitis, caused by Mycobacterium bovis. Brain biopsy was reviewed and confirmed the presence of perivascular mycobacteria. A retrospective diagnosis of BCG-induced central nervous system vasculitis was made and he was treated with high-dose corticosteroids, moxifloxacin, isoniazid, ethambutol, and rifampicin. BCG is a live attenuated form of Mycobacterium bovis widely used as tuberculosis vaccination and intravesical therapy for superficial forms of bladder cancer. Systemic complications affect roughly 5% of patients and can manifest months or years after the last instillation. Cases of endophthalmitis, meningitis, aortitis, or mycotic aneurysms have been described, but no reports of CNS vasculitis have been found. In disseminated forms of BCG infections, referred to as BCGitis, histopathology usually reveals granulomatous inflammation. Mycobacterial cultures are often negative, making this a diagnostic challenge. This is the first documented case of BCG-induced small-vessel CNS vasculitis. Mycobacterium bovis infection is rare and findings are often nonspecific, making the diagnosis very difficult. Other infectious and non-infectious causes must be ruled out appropriately before considering this entity.
Literature
1.
Calabrese LH, Mallek JA (1988) Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine 67(1):20–39CrossRefPubMed
2.
Hajj-Ali RA, Calabrese LH (2013) Primary angiitis of the central nervous system. Autoimmun Rev 12(4):463–466. https://​doi.​org/​10.​1016/​j.​autrev.​2012.​08.​004 CrossRefPubMed
3.
Salvarani C, Brown RDJ, Calamia KT, Christianson TJH, Weigand SD, Miller DV et al (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62(5):442–451. https://​doi.​org/​10.​1002/​ana.​21226 CrossRefPubMed
4.
Hajj-Ali RA, Calabrese LH (2014) Diagnosis and classification of central nervous system vasculitis. J Autoimmun 48–49:149–152. https://​doi.​org/​10.​1016/​j.​jaut.​2014.​01.​007 CrossRefPubMed
5.
Javaud N, Certal RDS, Stirnemann J, Morin AS, Chamouard JM, Augier A, Bouchaud O, Carpentier A, Dhote R, Dumas JL, Fantin B, Fain O (2011) Tuberculous cerebral vasculitis: retrospective study of 10 cases. Eur J Intern Med 22(6):e99–e104. https://​doi.​org/​10.​1016/​j.​ejim.​2011.​04.​004 CrossRefPubMed
6.
Kakumani PL, Hajj-Ali RA (2009) A forgotten cause of central nervous system vasculitis. J Rheumatol 36(3):655. https://​doi.​org/​10.​3899/​jrheum.​080605 CrossRefPubMed
7.
Flint AC, Liberato BB, Anziska Y, Schantz-Dunn J, Wright CB (2005) Meningovascular syphilis as a cause of basilar artery stenosis. Neurology 64(2):391–392. https://​doi.​org/​10.​1212/​01.​WNL.​0000149758.​57386.​B8 CrossRefPubMed
8.
Ehrengut W (1990) BCG-induced inflammation during childhood and in pregnancy. Additionally a contribution to BCG-induced necrotising cerebral arteritis. Klin Padiatr 202(5):303–307. https://​doi.​org/​10.​1055/​s-2007-1025536 CrossRefPubMed
9.
Gavito-Higuera J, Mullins CB, Ramos-Duran L, Olivas Chacon CI, Hakim N, Palacios E (2016) Fungal infections of the central nervous system: a pictorial review. J Clin Imaging Sci 6:24. https://​doi.​org/​10.​4103/​2156-7514.​184244 CrossRefPubMedPubMedCentral
10.
Parisi JE, Moore PM (1994) The role of biopsy in vasculitis of the central nervous system. Semin Neurol 14(4):341–348. https://​doi.​org/​10.​1055/​s-2008-1041093 CrossRefPubMed
11.
Alrawi A, Trobe JD, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53(4):858–860CrossRefPubMed
12.
Sienknecht CW, Whetsell WOJ, Pollock P (1995) Intravascular malignant lymphoma (“malignant angioendotheliomatosis”) mimicking primary angiitis of the central nervous system. J Rheumatol 22(9):1769–1770PubMed
13.
Prayson RA (2016) Intravascular lymphoma mimicking vasculitis. J Clin Neurosci 34:224–225. https://​doi.​org/​10.​1016/​j.​jocn.​2016.​06.​010 CrossRefPubMed
14.
Hundsberger T, Cogliatti S, Kleger G-R, Fretz C, Gahler A, Anliker M et al (2011) Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol 3(3):278–283. https://​doi.​org/​10.​1159/​000334130 CrossRefPubMedPubMedCentral
15.
Torres J, Loomis C, Cucchiara B, Smith M, Messé S (2016) Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis. Stroke 47(8):2127–2129CrossRefPubMed
16.
Shahane A, Khasnis A, Hajj Ali R (2012) Three unusual mimics of primary angiitis of the central nervous system. Rheumatol Int 32(3):737–742. https://​doi.​org/​10.​1007/​s00296-010-1679-8 CrossRefPubMed
17.
Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116(2):180–183CrossRefPubMed
18.
Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM et al (2016) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461. https://​doi.​org/​10.​1016/​j.​eururo.​2016.​05.​041 CrossRefPubMed
19.
Koya MP, Simon MA, Soloway MS (2006) Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 175(6):2004–2010. https://​doi.​org/​10.​1016/​S0022-5347(06)00264-3 CrossRefPubMed
20.
Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW et al (1992) Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147(3:596–600CrossRef
21.
Martinez-Pineiro JA, Jimenez Leon J, Martinez-Pineiro LJ, Fiter L, Mosteiro JA, Navarro J et al (1990) Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J Urol 143(3):502–506CrossRefPubMed
22.
Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouenan C, Rioux C et al (2015) Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients. Infect Dis 47(10):725–731. https://​doi.​org/​10.​3109/​23744235.​2015.​1055794 CrossRef
23.
Kamat AM, Bellmunt J, Galsky MD, Konety BR, Lamm DL, Langham D, Lee CT, Milowsky MI, O’Donnell MA, O’Donnell PH, Petrylak DP, Sharma P, Skinner EC, Sonpavde G, Taylor JA, Abraham P, Rosenberg JE (2017) Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. J Immunother cancer 5(1):68. https://​doi.​org/​10.​1186/​s40425-017-0271-0 CrossRefPubMedPubMedCentral
24.
Kassouf W, Kamat AM, Zlotta A, Bochner BH, Moore R, So A, Izawa J, Rendon RA, Lacombe L, Aprikian AG (2010) Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy. Can Urol Assoc J 4(3):168–173CrossRefPubMedPubMedCentral
25.
Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Lopez-Medrano F, Lumbreras C, Tejido A, San Juan R et al (2014) Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine 93(17):236–254. https://​doi.​org/​10.​1097/​MD.​0000000000000119​ CrossRefPubMedPubMedCentral
26.
Renard D, Morales R, Heroum C (2007) Tuberculous meningovasculitis. Neurology 68(20):1745. https://​doi.​org/​10.​1212/​01.​wnl.​0000263653.​20798.​09 CrossRefPubMed